Hypoglycemia Close to Discharge Is Associated with Worse Outcomes
Diabetic patients with hypoglycemia on the last day of hospitalization had higher readmission rates and postdischarge mortality.
Continua a leggereCategoria: Articoli in lingua originale
A possible downturn in rate of new cases of diabetes #EASD2019
While overall, the numbers (prevalence) of people with type 2 diabetes continue to grow at an alarming rate, new research presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 September) shows that recent studies suggest the rate at which
Continua a leggere
Gluten, Grains, and Risk for Type 1 Diabetes in At-Risk Children
Dietary factors have been implicated for many years as potential pathophysiologic triggers in the development of type 1 diabetes (T1D). High intake of cereals and other gluten-containing products may lead to an increased risk for islet autoimmunity (IA)
Continua a leggere
XERIS PHARMACEUTICALS RECEIVES U.S. FDA APPROVAL FOR GVOKE™ (GLUCAGON), THE FIRST READY-TO-USE STABLE LIQUID GLUCAGON FOR SEVERE HYPOGLYCEMIA
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations
Continua a leggere
High-Dose Vitamin D Might Reduce Bone Mineral Density
High-dose vitamin D supplements don’t appear to improve bone mineral density in healthy adults and may even have a negative impact, according to a JAMA study. Some 300 healthy adults aged 55 to 70 years were randomized to receive 400, 4000, or 10,000 IU of oral cholecalciferol daily for 3 years. Higher
Continua a leggere
Age-focused diabetes education improves HbA1c, self-management
Adolescents and young adults with type 1 diabetes who took part in a diabetes education course that was specifically designed for their age group achieved lower HbA1c
Continua a leggere
Mediterranean Eating Plan May Help Keep T2DM Patients Off Meds
A Mediterranean eating plan (Med-EatPlan) plus extra virgin olive oil (EVOO) may delay the need for first glucose-lowering medication among participants with type 2 diabetes, according to a study published in the August issue of Diabetes Care. F. Javier Basterra-Gortari, M.D., Ph.D., from the University of Navarra in Pamplona, Spain, and
Continua a leggere
Preventing Type 1 Diabetes with Teplizumab
An anti-CD3 antibody therapy significantly delayed onset of clinical diabetes in an at-risk population with diabetes autoantibodies. Because type 1 diabetes mellitus (DM) is the result of immune destruction of pancreatic islet cells, immunologic interventions have shown promise in delaying its onset.
Continua a leggere
Serious Hypoglycemia at Both High and Low Glycosylated Hemoglobin Levels
In a study published in 2013, serious hypoglycemia was associated with both high (>9%) and low (<6%) levels of glycosylated hemoglobin (HbA1c) in patients with type 2 diabetes — a so-called U-shaped association (NEJM JW Gen Med Jan 15 2014 and Diabetes Care 2013; 36:3535). Now, another research group has examined this issue.
Continua a leggere
